Paris-based platform for the healthcare industry Doctolib has raised €500 million in equity and debt funding, now giving the company a valuation of €5.8 billion. With this number, Doctolib officially overtakes Back Market as the highest valued French startup.
The funding will be used to further fuel a recruitment drive that’s aimed at bringing over 3,500 new employees to the table over the next five years.
Taking a page from the Salesforce playbook, Doctolib, which started out life as a booking and scheduling platform has been progressively adding services to the lineup including telemedicine, an instant messaging service, and back-office functionalities. With this play, the end-goal for the company is to become so embedded in the daily operations of the healthcare industry that they go from ‘nice to have' to 'essential'.
The company currently operates in France, Germany, and Italy, and counts over 300,000 medical professionals utilising the €129 per month SaaS service. With these two numbers in mind, that would place Doctolibs’ monthly recurring revenues close to €40 million.
The newest funding for Doctolib sees existing investor Eurazeo leading the round, with previous investors Bpifrance and General Atlantic participating.
Would you like to write the first comment?
Login to post comments